Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking. [electronic resource] by
- Ren, Ji-Xia
- Li, Lin-Li
- Zheng, Ren-Lin
- Xie, Huan-Zhang
- Cao, Zhi-Xing
- Feng, Shan
- Pan, You-Li
- Chen, Xin
- Wei, Yu-Quan
- Yang, Sheng-Yong
Producer: 20111021
In:
Journal of chemical information and modeling vol. 51
Availability: No items available.
|
|
|
8.
|
Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway invitro and inhibits tumor growth invivo. [electronic resource] by
- Xu, You-Zhi
- Zheng, Ren-Lin
- Zhou, Yan
- Peng, Feng
- Lin, Hong-Jun
- Bu, Qian
- Mao, Yong-Qiu
- Yu, Luo-Ting
- Yang, Li
- Yang, Sheng-Yong
- Zhao, Ying-Lan
Producer: 20120109
In:
Cancer letters vol. 313
Availability: No items available.
|
|
|
9.
|
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl)-N8-phenyl-9H-purine-2,8-diamine derivatives, a new class of reversible kinase inhibitors targeting both EGFR-activating and resistance mutations. [electronic resource] by
- Yang, Jiao
- Wang, Li-Jiao
- Liu, Jing-Jing
- Zhong, Lei
- Zheng, Ren-Lin
- Xu, Yong
- Ji, Pan
- Zhang, Chun-Hui
- Wang, Wen-Jing
- Lin, Xing-Dong
- Li, Lin-Li
- Wei, Yu-Quan
- Yang, Sheng-Yong
Producer: 20130226
In:
Journal of medicinal chemistry vol. 55
Availability: No items available.
|
|
|
10.
|
Taking quinazoline as a general support-Nog to design potent and selective kinase inhibitors: application to FMS-like tyrosine kinase 3. [electronic resource] by
- Li, Wei-Wei
- Chen, Jin-Juan
- Zheng, Ren-Lin
- Zhang, Wen-Qin
- Cao, Zhi-Xing
- Yang, Ling-Ling
- Qing, Xiao-Yu
- Zhou, Liang-Xue
- Yang, Li
- Yu, Luo-Ding
- Chen, Li-Juan
- Wei, Yu-Quan
- Yang, Sheng-Yong
Producer: 20100708
In:
ChemMedChem vol. 5
Availability: No items available.
|
|
|
11.
|
Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: synthesis, preliminary structure-activity relationships, and in vitro biological evaluation. [electronic resource] by
- Zeng, Xiu-Xiu
- Zheng, Ren-Lin
- Zhou, Tian
- He, Hai-Yun
- Liu, Ji-Yan
- Zheng, Yu
- Tong, Ai-Ping
- Xiang, Ming-Li
- Song, Xiang-Rong
- Yang, Sheng-Yong
- Yu, Luo-Ting
- Wei, Yu-Quan
- Zhao, Ying-Lan
- Yang, Li
Producer: 20110124
In:
Bioorganic & medicinal chemistry letters vol. 20
Availability: No items available.
|
|
|
12.
|
SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo. [electronic resource] by
- Cao, Zhi-Xing
- Zheng, Ren-Lin
- Lin, Hong-Jun
- Luo, Shi-Dong
- Zhou, Yan
- Xu, You-Zhi
- Zeng, Xiu-Xiu
- Wang, Zhao
- Zhou, Li-Na
- Mao, Yong-Qiu
- Yang, Li
- Wei, Yu-Quan
- Yu, Luo-Ting
- Yang, Sheng-Yong
- Zhao, Ying-Lan
Producer: 20111003
In:
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology vol. 27
Availability: No items available.
|
|
|
13.
|
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivo. [electronic resource] by
- Li, Wei-Wei
- Wang, Xiao-Yan
- Zheng, Ren-Lin
- Yan, Heng-Xiu
- Cao, Zhi-Xing
- Zhong, Lei
- Wang, Ze-Rong
- Ji, Pan
- Yang, Ling-Ling
- Wang, Li-Jiao
- Xu, Yong
- Liu, Jing-Jing
- Yang, Jiao
- Zhang, Chun-Hui
- Ma, Shuang
- Feng, Shan
- Sun, Qi-Zheng
- Wei, Yu-Quan
- Yang, Sheng-Yong
Producer: 20120717
In:
Journal of medicinal chemistry vol. 55
Availability: No items available.
|